Avanos Medical Inc Q3 2024 Earnings Call Highlights Strong Financial Performance Amid ...
| AVNS Stock | USD 16.18 0.84 4.94% |
Slightly above 61% of Avanos Medical's investor base is looking to short. The analysis of overall sentiment of trading Avanos Medical stock suggests that many investors are alarmed at this time. Avanos Medical's investing sentiment can be driven by a variety of factors including economic data, Avanos Medical's earnings reports, geopolitical events, and overall market trends.
Avanos |
Revenue Approximately 170 million from continuing operations.Adjusted Diluted Earnings Per Share 0.36.Adjusted EBITDA Approximately 31 million, or almost
Read at gurufocus.com
 |
Avanos Medical Fundamental Analysis
We analyze Avanos Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avanos Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avanos Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Current Liabilities
Current Liabilities Comparative Analysis
Avanos Medical is currently under evaluation in current liabilities category among its peers. Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Avanos Medical Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Avanos Medical stock to make a market-neutral strategy. Peer analysis of Avanos Medical could also be used in its relative valuation, which is a method of valuing Avanos Medical by comparing valuation metrics with similar companies.
Peers
Avanos Medical Related Equities
| GKOS | Glaukos Corp | 1.54 | ||||
| SRDX | SurModics | 0.12 | ||||
| KIDS | Orthopediatrics Corp | 0.58 | ||||
| OFIX | Orthofix Medical | 2.23 | ||||
| ESTA | Establishment Labs | 2.49 | ||||
| CNMD | CONMED | 2.68 | ||||
| AXGN | Axogen | 2.71 | ||||
| FNA | Paragon 28 | 3.09 | ||||
| ANIK | Anika Therapeutics | 3.49 | ||||
| ITGR | Integer Holdings | 3.79 | ||||
| AORT | Artivion | 3.84 | ||||
| LIVN | LivaNova PLC | 4.71 | ||||
| SGHT | Sight Sciences | 5.80 | ||||
| TMCI | Treace Medical | 6.97 | ||||
| NVRO | Nevro Corp | 7.65 |
Additional Tools for Avanos Stock Analysis
When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.